Literature DB >> 10333837

Radiofrequency radiation exposure and other environmental concerns.

R House.   

Abstract

Mesh：

Year:  1999        PMID： 10333837      PMCID： PMC1230317     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  13 in total

1.  The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; S Granqvist; M Holmström; A Carlsson; P Lindmarker; P Nicol; S G Eklund; S Nordlander; G Lärfars; B Leijd; O Linder; E Loogna
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

2.  The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).

Authors:  P Simioni; P Prandoni; A W Lensing; A Scudeller; C Sardella; M H Prins; S Villalta; F Dazzi; A Girolami
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

3.  Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group.

Authors:  S Schulman; E Svenungsson; S Granqvist
Journal:  Am J Med       Date:  1998-04       Impact factor: 4.965

4.  Radiofrequency radiation activities and issues: a 1986 perspective.

Authors:  J A Elder
Journal:  Health Phys       Date:  1987-12       Impact factor: 1.316

5.  A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Authors:  S Schulman; A S Rhedin; P Lindmarker; A Carlsson; G Lärfars; P Nicol; E Loogna; E Svensson; B Ljungberg; H Walter
Journal:  N Engl J Med       Date:  1995-06-22       Impact factor: 91.245

6.  Risk communication and occupational medicine.

Authors:  V T Covello
Journal:  J Occup Med       Date:  1993-01

7.  A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

Authors:  C Kearon; M Gent; J Hirsh; J Weitz; M J Kovacs; D R Anderson; A G Turpie; D Green; J S Ginsberg; P Wells; B MacKinnon; J A Julian
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

8.  Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.

Authors:  D H Ryan; M A Crowther; J S Ginsberg; C W Francis
Journal:  Ann Intern Med       Date:  1998-02-15       Impact factor: 25.391

9.  The long-term clinical course of acute deep venous thrombosis.

Authors:  P Prandoni; A W Lensing; A Cogo; S Cuppini; S Villalta; M Carta; A M Cattelan; P Polistena; E Bernardi; M H Prins
Journal:  Ann Intern Med       Date:  1996-07-01       Impact factor: 25.391

Review 10.  Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.

Authors:  P M Ridker
Journal:  Vasc Med       Date:  1998       Impact factor: 3.239
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.